Price T Rowe Associates Inc Pro Phase Labs, Inc. Transaction History
Price T Rowe Associates Inc
- $883 Billion
- Q2 2025
A detailed history of Price T Rowe Associates Inc transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 16,858 shares of PRPH stock, worth $5,900. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,858
Previous 17,300
2.55%
Holding current value
$5,900
Previous $7,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding PRPH
# of Institutions
34Shares Held
2.68MCall Options Held
12.3KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$225,6780.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$142,8930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$90,6720.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$80,3080.0% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA218KShares$76,3440.01% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.61M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...